Insider Transactions in Q4 2021 at Eli Lilly & CO (LLY)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,614
-0.0%
|
$1,008,306
$279.55 P/Share
|
|
Dec 27
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,570
-0.0%
|
$996,030
$279.53 P/Share
|
|
Dec 20
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.08%
|
-
|
|
Dec 20
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+3.39%
|
$9,731
$263.48 P/Share
|
|
Dec 20
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.01%
|
$2,104
$263.48 P/Share
|
|
Dec 16
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
177,616
-0.04%
|
$49,910,096
$281.39 P/Share
|
|
Dec 15
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.02%
|
$55,555,000
$271.49 P/Share
|
|
Nov 15
2021
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+50.0%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
685
+0.55%
|
$176,730
$258.43 P/Share
|
|
Nov 15
2021
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+4.27%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+0.98%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
719
+0.7%
|
$185,502
$258.43 P/Share
|
|
Nov 15
2021
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+4.8%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+3.08%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+12.03%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+3.32%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+8.02%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Michael L Eskew Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+1.48%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
658
+23.29%
|
$169,764
$258.43 P/Share
|
|
Nov 04
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
195,000
-0.03%
|
$52,260,000
$268.86 P/Share
|
|
Oct 28
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
178,631
-0.03%
|
$45,372,274
$254.46 P/Share
|
|
Oct 27
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
21,369
-0.02%
|
$5,384,988
$252.33 P/Share
|
|
Oct 18
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.01%
|
$1,904
$238.98 P/Share
|
|
Oct 18
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+10.15%
|
$9,520
$238.98 P/Share
|
|
Oct 18
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.09%
|
$10,948
$238.98 P/Share
|